Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 2/20 | 0.34 |
| ▸ | SCN4A | P35499 | 2/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | GPR183 | P32249 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ITK | Q08881 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23995357 | 0.82 | P2RX3 (0.33) | ACACBSCN4ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL25004973 | 0.81 | SMN1; SMN2 (0.46) | NPC1RAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL25005274 | 0.80 | HTR2C (0.34) | ACACBSCN4AEPHX2CYP2D6GPR183 | |
| SCHEMBL23994238 | 0.74 | SNCA (0.32) | SCN4AEPHX2CYP2D6GPR183KCNH2 | |
| SCHEMBL25005865 | 0.74 | SNCA (0.32) | SCN4AEPHX2CYP2D6GPR183KCNH2 | |
| SCHEMBL25004337 | 0.74 | TLR7 (0.33) | — | |
| SCHEMBL17050421 | 0.72 | RAB9A (0.59) | SCN4AEPHX2GPR183KCNH2DYRK1A | |
| SCHEMBL23993216 | 0.71 | SLC6A2 (0.43) | DYRK1ANPC1RAB9ASMN1; SMN2 | |
| SCHEMBL25004754 | 0.70 | SMN1; SMN2 (0.43) | NPC1RAB9ASMN1; SMN2KMT2A | |
| SCHEMBL17547128 | 0.70 | RAB9A (0.56) | SCN4AEPHX2DYRK1ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039553-A1 | CD73 COMPOUNDS | GILEAD SCIENCES, INC. | 2023-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230039553-A1 | CD73 COMPOUNDS | ENTPD5, ENTPD1, NT5E | ACACB 2113/4885SCN4A 2524/4885EPHX2 985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.